| Active ingredient (INN) | Lorazepam |
|---|---|
| Brand names | Apo |
| ATC level 5 | N05BA06 |
| ATC level 4 | N05BA |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| WHO Essential Medicine | Yes (2023) |
| Controlled substance | No |
| Marketing-authorisation holders | Southern Cross Pharma Pty Ltd, SANDOZ LIMITED, MERCURY PHARMACEUTICALS LIMITED, MANX HEALTHCARE LIMITED +6 more |
| Registrations on file | 17 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Lupin | 1 mg | — | 🇦🇺 AU | Southern Cross Pharma Pty Ltd | Active |
| LORAZE lorazepam | 4 mg | — | 🇦🇺 AU | — | Active |
| Sxp | 4 mg | — | 🇦🇺 AU | — | Active |
| Ajs | 4 mg | — | 🇦🇺 AU | — | Active |
| Wgr | 2.5 mg | — | 🇦🇺 AU | Southern Cross Pharma Pty Ltd | Active |
| Wgr | 1 mg | — | 🇦🇺 AU | Southern Cross Pharma Pty Ltd | Active |
| LORAZEPAM TABLETS 1MG | 1MG | tablet | 🇬🇧 GB | SANDOZ LIMITED | Active |
| LORAZEPAM TABLETS 2.5MG | 2.5MG | tablet | 🇬🇧 GB | SANDOZ LIMITED | Active |
| LORAZEPAM 0.5 MG TABLETS | 0.5 MG | tablet | 🇬🇧 GB | MERCURY PHARMACEUTICALS LIMITED | Active |
| LORAZEPAM 1MG TABLETS | 1MG | tablet | 🇬🇧 GB | MANX HEALTHCARE LIMITED | Active |
| LORAZEPAM 2.5MG TABLETS | 2.5MG | tablet | 🇬🇧 GB | MANX HEALTHCARE LIMITED | Active |
| LORAZEPAM 2.5 MG TABLETS | 2.5 MG | tablet | 🇬🇧 GB | MORNINGSIDE HEALTHCARE LIMITED | Active |
| LORAZEPAM 1 MG TABLETS | 1 MG | tablet | 🇬🇧 GB | CRESCENT PHARMA LIMITED | Active |
| Lorazepam Orion | 1 MG | tablet | 🇬🇧 GB | ORION CORPORATION | Active |
| LORAZEPAM 2.5MG TABLETS | 2.5MG | tablet | 🇬🇧 GB | RIVOPHARM (UK) LIMITED | Active |